Renal cell carcinoma in South Korea: A multicenter study

The incidence of renal cell carcinoma (RCC) in South Korea is steadily becoming similar to that in Western countries. This study summarizes the results of a 3-year multicenter survey of RCC in South Korea, conducted by the Korean Genitourinary Pathology Study Group. A total of 795 cases of RCC were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 2004-12, Vol.35 (12), p.1556-1563
Hauptverfasser: Kim, Haeryoung, Cho, Nam Hoon, Kim, Dong-Sug, Kwon, Young-Mi, Kim, Eun Kyung, Rha, Seo Hee, Park, Yong Wook, Shim, Jung Weon, Lee, Sang Sook, Lee, Shi Nae, Lee, Juhie, Lee, Jin Sook, Lee, Tae-Jin, Jung, Soo Jin, Jung, Soon-Hee, Chung, Jin Haeng, Cho, Hyun Yee, Joo, Hee Jae, Choi, Yeong-Jin, Choi, Chan, Han, Woon Sup, Hur, Bang, Ro, Jae Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The incidence of renal cell carcinoma (RCC) in South Korea is steadily becoming similar to that in Western countries. This study summarizes the results of a 3-year multicenter survey of RCC in South Korea, conducted by the Korean Genitourinary Pathology Study Group. A total of 795 cases of RCC were collected from 20 institutes between 1995 and 1997, including 686 clear cell RCCs (86.3%), 58 papillary RCCS (7.30%), 49 chromphobe RCCs (6.16%), and 2 collecting duct RCCs (0.25%). At least 5 years of follow-up was available for 627 clear cell, 54 papillary, and 49 chromophobe RCCs. All subtypes presented most frequently with stage T3aN0M0 at the time of operation, and papillary RCCs demonstrated more frequent lymph node metastasis. Overall survival was not significantly related to the histological subtype (clear cell vs papillary, P = 0.8651; clear cell vs chromophobe, P = 0.0584; papillary vs chromophobe, P = 0.0743). For clear cell RCCs, statistically significant associations were found between overall survival and sex ( P = 0.0153), multiplicity ( P = 0.0461), necrosis ( P = 0.0191), age, sarcomatoid change, TNM stage, nuclear grade, and modality of treatment (all P
ISSN:0046-8177
1532-8392
DOI:10.1016/j.humpath.2004.06.011